Postoperative Headache in Acoustic Neuroma

Vijayan, N.

doi:10.1111/j.1526-4610.1995.hed3502098.x

Cited by 47 publications

(49 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Three of these five patients had posterior fossa surgery (two in the codeine group and one in the tramadol group), and two had temporal craniotomy via a pterional approach with stripping the temporalis muscle (one tramadol and one codeine). Both of these approaches have been previously identified as resulting in higher levels of postoperative pain [20,21]. Three of these patients received remifentanil alone intra-operatively, which may have contributed to their severe initial pain.…”

Section: Discussionmentioning

confidence: 99%

Comparison of the analgesic efficacy and respiratory effects of morphine, tramadol and codeine after craniotomy*

et al. 2007

View full text Add to dashboard Cite

SummaryPain after craniotomy remains a significant problem. The effect of morphine and tramadol patient‐controlled analgesia (PCA) on arterial carbon dioxide tension is unknown in patients having such surgery. Sixty craniotomy patients were randomly allocated to receive morphine PCA, tramadol PCA or codeine phosphate 60 mg intramuscularly. Baseline values of pain score (0–10), sedation and arterial carbon dioxide tension were recorded at the time of first analgesic administration and at 30 min, 1, 4, 8, 12, 18 and 24 h. Patient satisfaction was assessed at 24 h. There were no differences in arterial carbon dioxide tension or sedation between groups at any time, but in all three groups some patients had rises greater than 1 kPa. Morphine produced significantly better analgesia than tramadol at all time points (p < 0.005) and better analgesia than codeine at 4, 12 and 18 h. Patients were more satisfied with morphine than with codeine or tramadol (p < 0.001). Vomiting and retching occurred in 50% of patients with tramadol, compared with 20% with morphine and 29% with codeine.

show abstract

Section: Discussionmentioning

confidence: 99%

Comparison of the analgesic efficacy and respiratory effects of morphine, tramadol and codeine after craniotomy*

et al. 2007

View full text Add to dashboard Cite

show abstract

“…Although there are currently no studies in the VS literature focusing on longitudinal change in headache symptoms following SRS and conservative observation, surgical series have reported a frequency of baseline headache ranging from 9% to 50% and a prevalence of posttreatment headache ranging from 0% to 75%. 17,24,28,37,38,44,45,47 The low rate of headache seen in some studies is perplexing since, within the general population, the estimated lifetime prevalence of headache is approximately 60%-80%, with roughly 40%-60% of individuals experiencing headaches each year. 42,43 This significant disparity probably stems from heterogeneous study methodology, varying definitions of headache, and differing lengths of follow-up.…”

Section: Prevalence Of Headache In Patients With Sporadic Vsmentioning

confidence: 99%

Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study

Carlson¹,

Tveiten

Driscoll³

et al. 2015

JNS

View full text Add to dashboard Cite

O ver the last 100 years, the treatment of vestibular schwannoma (VS) has undergone tremendous evolution. 32 With the increasing use of less invasive management methods including observation, stereotactic radiosurgery (SRS), or radiotherapy and subtotal or neartotal resection, incidences of disease-associated mortality, stroke, and permanent facial neuropathy have been substantially reduced. 12,27,32,41 obJect The primary goals of this study were: 1) to examine the influence of disease and treatment on headache in patients with sporadic vestibular schwannoma (VS); and 2) to identify clinical predictors of long-term headache disability.methods This was a cross-sectional observational study with international multicenter enrollment. Patients included those with primary sporadic < 3-cm VS and a separate group of general population control subjects without tumors. Interventions included a postal survey incorporating the Headache Disability Inventory (HDI), the Hospital Anxiety and Depression Scale, and a VS symptom questionnaire. The main outcome measures were univariate and multivariable associations with HDI total score. results The overall survey response rate was 79%. Data from 538 patients with VS were analyzed. The mean age at time of survey was 64 years, 56% of patients were female, and the average duration between treatment and survey was 7.7 years. Twenty-seven percent of patients received microsurgery, 46% stereotactic radiosurgery, and 28% observation. Patients with VS who were managed with observation were more than twice as likely to have severe headache disability compared with 103 control subjects without VS. When accounting for baseline differences, there was no statistically significant difference in HDI outcome between treatment modalities at time of survey. Similarly, among the microsurgery cohort, the long-term risk of severe headache disability was not different between surgical approaches. Multivariable regression demonstrated that younger age, greater anxiety and depression, and a preexisting diagnosis of headache were the primary predictors of severe long-term headache disability, while tumor size and treatment modality had little influence. coNclusioNs At a mean of almost 8 years following treatment, approximately half of patients with VS experience headaches of varying frequency and severity. Patient-driven factors including age, sex, mental health, and preexisting headache syndrome are the strongest predictors of long-term severe headache disability. Tumor size and treatment modality have less impact. These data may assist with patient counseling regarding long-term expectations following diagnosis and treatment.

show abstract

“…In addition to other common persistent postsurgical issues, including hearing loss, gait ataxia, and facial paresis, headache has a prevalence of 75% [35]. Headache may mimic other primary and secondary morphologies including tension-type headache (47%); occipital (17%), trigeminal (17%), or nervus intermedius (10%) neuralgias; and cervicogenic headache (10%), with one third of patients reporting chronic persistent moderate to severe pain at 6 months [36].…”

Section: Postcraniotomy Headachementioning

confidence: 98%

Headache in Patients with Cancer

Goldlust

Graber

Bossert

et al. 2010

Curr Pain Headache Rep

View full text Add to dashboard Cite

Contemporary cancer research has led to unparalleled advances in therapeutics and improved survival. Even as treatment options continue to improve, quality of life should remain a priority. Headache drastically impacts the quality of life of patients with cancer and has a wide etiological scope, making diagnosis a challenge. Intracranial mass lesions are only one cause; others include extracranial tumors, paraneoplastic processes, and the consequences of diagnostic and therapeutic interventions used in cancer care. Fortunately, cancer-related headache is treatable, but a sound understanding of the variable etiologies is crucial to appropriate diagnostic evaluation and treatment. In this review, we highlight the important causes of headache in the patient with cancer, and consider the epidemiology, pathophysiology, clinical course, and treatment options for each.

show abstract

Postoperative Headache in Acoustic Neuroma

Cited by 47 publications

References 0 publications

Comparison of the analgesic efficacy and respiratory effects of morphine, tramadol and codeine after craniotomy*

Comparison of the analgesic efficacy and respiratory effects of morphine, tramadol and codeine after craniotomy*

Risk factors and analysis of long-term headache in sporadic vestibular schwannoma: a multicenter cross-sectional study

Headache in Patients with Cancer

Contact Info

Product

Resources

About